FOR THE NEXT GENERATION OF PHYSICIANS
← All USMLE guides
BIOSTATISTICS, EPIDEMIOLOGY AND ETHICS

Study designs: cohort, case-control, cross-sectional and randomized trials.

Choosing the right study design, which measures each gives (relative risk vs odds ratio) and the strengths and limits of each.

Study design questions ask what a study can measure. Case-control gives odds ratios; cohort gives relative risk.

Designs

  • Randomized controlled trial: gold standard for treatment effect; randomization balances confounders; blinding reduces bias.
  • Cohort: follows exposed and unexposed groups for outcomes; calculates incidence and relative risk; good for rare exposures.
  • Case-control: starts with disease and compares exposures; calculates odds ratio; good for rare diseases; prone to recall bias.
  • Cross-sectional: measures prevalence at one time; cannot show temporality.
  • Case series and case report: descriptive only.

Meta-analysis

Pools data from multiple studies to increase power; heterogeneity and publication bias limit it.

Choosing

Rare disease: case-control. Rare exposure: cohort. Treatment efficacy: randomized trial. Prevalence: cross-sectional.

Keep going in biostatistics, epidemiology and ethics

Related on USMLE WEB

Frequently asked questions

Which study design gives odds ratios?

Case-control.

Which design is best for a rare disease?

Case-control.